Alexandria Group Oyj

Alexandria Group Oyj has a basic and diluted share count of 11,032,504, indicating no dilution from stock options or convertible securities. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

The company's profitability and returns are not available for comparison against industry_config preferred metrics or cohort medians, as no valuation snapshot data is provided. This lack of data limits the ability to assess its performance relative to peers in the Investment Management & Fund Operators industry.

Segment and geographic exposure details are not disclosed in the available data, making it difficult to evaluate revenue concentration or geographic diversification. Without segment-specific revenue data, it is not possible to determine if the company is overexposed to any particular market or product line.

Growth trajectory is also unclear, as no outlook numeric deltas or revenue history is provided. Analysts have not issued any price targets or recommendations, with all estimates showing a mean price target of 11.50 EUR and a mean recommendation of 4.00 (neutral).

The company's risk profile is limited to a low dilution risk, with no other risk factors identified in the available data. No dilution sources are disclosed, and no adjustments have been applied to the valuation metrics.

Recent events, including filings and transcripts, are not available in the provided data, which limits the ability to assess any recent developments that may impact the company's operations or financial performance.

Revenue grew 10.8% year-over-year to EUR 54.7 million, demonstrating strong top-line expansion momentum.

Total assets expanded by 22.5% year-over-year, indicating significant balance sheet growth and operational scaling.

Equity increased by 10.0% year-over-year, reflecting a strengthening capital base for future operations.

Operating income remained stable at EUR 11.2 million, showing resilience in core profitability metrics.

Dilution risk is assessed as low, suggesting limited immediate threat to existing shareholder value.

Long-term debt rose to EUR 6.8 million, increasing leverage and potential financial risk exposure.

The sole analyst recommendation is a sell, indicating negative professional sentiment on the stock.

Net income CAGR is negative at -2.9% over four years, highlighting long-term earnings deterioration.

Revenue €54.7M, +10,8% YoY; Operating income +0,6% YoY.

• ▍Revenue €54.7M, +10,8% YoY
• ▍Operating income +0,6% YoY
• ▍Net income −2,9% YoY
• ▍Free cash flow −27,0% YoY
• ▍Net margin 14.2%

Revenue €49.4M, +11,3% YoY; Operating income +7,7% YoY.

• ▍Revenue €49.4M, +11,3% YoY
• ▍Operating income +7,7% YoY
• ▍Net income −0,6% YoY
• ▍Free cash flow −62,6% YoY
• ▍Net margin 16.2%

Revenue €44.4M, +16,2% YoY; Operating income +88,4% YoY.

• ▍Revenue €44.4M, +16,2% YoY
• ▍Operating income +88,4% YoY
• ▍Net income +109,2% YoY
• ▍Free cash flow +1 498,7% YoY
• ▍Net margin 18.2%

Revenue €38.2M, −19,5% YoY; Operating income −52,7% YoY.

• ▍Revenue €38.2M, −19,5% YoY
• ▍Operating income −52,7% YoY
• ▍Net income −55,9% YoY
• ▍Free cash flow −104,0% YoY
• ▍Net margin 10.1%

Revenue €47.4M; Operating income €11.6M.

• ▍Revenue €47.4M
• ▍Operating income €11.6M
• ▍Net margin 18.4%